Cargando…

Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead

This study identified existing issues related to quantitative pharmaceutical risk assessment (QPhRA, hereafter) for pharmaceuticals in water and proposed possible solutions by analyzing methodologies and findings of different published QPhRA studies. Retrospective site-specific QPhRA studies from di...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Arun, Chang, Biao, Xagoraraki, Irene
Formato: Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996217/
https://www.ncbi.nlm.nih.gov/pubmed/21139869
http://dx.doi.org/10.3390/ijerph7113929
_version_ 1782193167633743872
author Kumar, Arun
Chang, Biao
Xagoraraki, Irene
author_facet Kumar, Arun
Chang, Biao
Xagoraraki, Irene
author_sort Kumar, Arun
collection PubMed
description This study identified existing issues related to quantitative pharmaceutical risk assessment (QPhRA, hereafter) for pharmaceuticals in water and proposed possible solutions by analyzing methodologies and findings of different published QPhRA studies. Retrospective site-specific QPhRA studies from different parts of the world (U.S.A., United Kingdom, Europe, India, etc.) were reviewed in a structured manner to understand different assumptions, outcomes obtained and issues, identified/addressed/raised by the different QPhRA studies. Till date, most of the published studies have concluded that there is no appreciable risk to human health during environmental exposures of pharmaceuticals; however, attention is still required to following identified issues: (1) Use of measured versus predicted pharmaceutical concentration, (2) Identification of pharmaceuticals-of-concern and compounds needing special considerations, (3) Use of source water versus finished drinking water-related exposure scenarios, (4) Selection of representative exposure routes, (5) Valuation of uncertainty factors, and (6) Risk assessment for mixture of chemicals. To close the existing data and methodology gaps, this study proposed possible ways to address and/or incorporation these considerations within the QPhRA framework; however, more research work is still required to address issues, such as incorporation of short-term to long-term extrapolation and mixture effects in the QPhRA framework. Specifically, this study proposed a development of a new “mixture effects-related uncertainty factor” for mixture of chemicals (i.e., mixUF(composite)), similar to an uncertainty factor of a single chemical, within the QPhRA framework. In addition to all five traditionally used uncertainty factors, this uncertainty factor is also proposed to include concentration effects due to presence of different range of concentration levels of pharmaceuticals in a mixture. However, further work is required to determine values of all six uncertainty factors and incorporate them to use during estimation of point-of-departure values within the QPhRA framework.
format Text
id pubmed-2996217
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-29962172010-12-06 Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead Kumar, Arun Chang, Biao Xagoraraki, Irene Int J Environ Res Public Health Review This study identified existing issues related to quantitative pharmaceutical risk assessment (QPhRA, hereafter) for pharmaceuticals in water and proposed possible solutions by analyzing methodologies and findings of different published QPhRA studies. Retrospective site-specific QPhRA studies from different parts of the world (U.S.A., United Kingdom, Europe, India, etc.) were reviewed in a structured manner to understand different assumptions, outcomes obtained and issues, identified/addressed/raised by the different QPhRA studies. Till date, most of the published studies have concluded that there is no appreciable risk to human health during environmental exposures of pharmaceuticals; however, attention is still required to following identified issues: (1) Use of measured versus predicted pharmaceutical concentration, (2) Identification of pharmaceuticals-of-concern and compounds needing special considerations, (3) Use of source water versus finished drinking water-related exposure scenarios, (4) Selection of representative exposure routes, (5) Valuation of uncertainty factors, and (6) Risk assessment for mixture of chemicals. To close the existing data and methodology gaps, this study proposed possible ways to address and/or incorporation these considerations within the QPhRA framework; however, more research work is still required to address issues, such as incorporation of short-term to long-term extrapolation and mixture effects in the QPhRA framework. Specifically, this study proposed a development of a new “mixture effects-related uncertainty factor” for mixture of chemicals (i.e., mixUF(composite)), similar to an uncertainty factor of a single chemical, within the QPhRA framework. In addition to all five traditionally used uncertainty factors, this uncertainty factor is also proposed to include concentration effects due to presence of different range of concentration levels of pharmaceuticals in a mixture. However, further work is required to determine values of all six uncertainty factors and incorporate them to use during estimation of point-of-departure values within the QPhRA framework. Molecular Diversity Preservation International (MDPI) 2010-11 2010-11-05 /pmc/articles/PMC2996217/ /pubmed/21139869 http://dx.doi.org/10.3390/ijerph7113929 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Kumar, Arun
Chang, Biao
Xagoraraki, Irene
Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead
title Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead
title_full Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead
title_fullStr Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead
title_full_unstemmed Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead
title_short Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead
title_sort human health risk assessment of pharmaceuticals in water: issues and challenges ahead
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996217/
https://www.ncbi.nlm.nih.gov/pubmed/21139869
http://dx.doi.org/10.3390/ijerph7113929
work_keys_str_mv AT kumararun humanhealthriskassessmentofpharmaceuticalsinwaterissuesandchallengesahead
AT changbiao humanhealthriskassessmentofpharmaceuticalsinwaterissuesandchallengesahead
AT xagorarakiirene humanhealthriskassessmentofpharmaceuticalsinwaterissuesandchallengesahead